HEARTCARE-B (06609) has announced that its board of directors has recommended applying to relevant Chinese regulatory authorities for the issuance and allotment of no more than 7,025,592 A-shares of the company.
The proposal also includes seeking approval from the Shanghai Stock Exchange for the listing and trading of these A-shares on the Science and Technology Innovation Board (STAR Market).
The A-share issuance is contingent upon, among other conditions, approval by a special resolution of the company's shareholders at an upcoming extraordinary general meeting, as well as subsequent approval from the China Securities Regulatory Commission and the Shanghai Stock Exchange.
Comments